Clinical GCT Trial Design | Regulatory | Strategy, Innovation and Future Direction | Risk vs Hype - 2022 World Medical Innovation Forum

Clinical GCT Trial Design | Regulatory | Strategy, Innovation and Future Direction | Risk vs Hype

Clinical GCT Trial Design | Regulatory | Strategy, Innovation and Future Direction | Risk vs Hype

Monday, May 2, 2022

4:10 PM – 4:50 PM America Ballroom View Here

This panel will delve into clinical trials for GCT. How do these trials differ from those for conventional therapeutics? What are the key lessons learned from completed GCT trials? How is the regulatory landscape shifting and what will that mean for the future of GCT?

Moderator:
Angela Shen, MD
  • Vice President, Strategic Innovation Leaders, Mass General Brigham Innovation
Panelists:
Laura Aguilar, MD, PhD
  • Co-Founder, Candel Therapeutics
Matthew Frigault, MD
  • Clinical Director, Cellular Immunotherapy Program, MGH
  • Assistant Professor of Medicine, HMS
Arati Rao, MD
  • Senior Vice President, Clinical Development, PACT Pharma
John Rossi
  • VP Head of Translational Medicine, Syncopation Life Sciences